SOHO 2022 Tenth Annual Meeting

 

SOHO 2022 Tenth Annual Meeting
Avatar

SOHO 2022 Update on CD47 Targeting Antibodies

By SOHO 2022 Tenth Annual Meeting FEATURING Naval Daver
By SOHO 2022 Tenth Annual Meeting FEATURING Naval Daver
33 views
October 13, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Leukemia
06:06

SOHO 2022: Characteristics of Patients With Myelofibrosis Taking Rux…

SOHO 2022 Tenth Annual Meeting

L. Masarova

56 views
16:50

SOHO 2022: Role of ddPCR in CML Today

SOHO 2022 Tenth Annual Meeting

J. Radich, S. Soverini

23 views
15:48

SOHO 2022: State of the Art in CML

SOHO 2022 Tenth Annual Meeting

M. Deininger, G. Saglio

247 views
08:51

SOHO 2022: Long-Term Outcomes After Haplo-SCT for Hematologic Malign…

SOHO 2022 Tenth Annual Meeting

S. Saengboon

137 views
09:22

GLOW Study - First Prospective Data on MRD Outcomes After Fixed-Dura…

SOHO 2022 Tenth Annual Meeting

C. Owen

102 views
09:54

SOHO 2022 Next Questions: CML

SOHO 2022 Tenth Annual Meeting

T. Hughes

72 views
08:27

SOHO 2022 Next Questions: CLL

SOHO 2022 Tenth Annual Meeting

F. Cymbalista

39 views
12:33

SOHO 2022 Next Questions: AML

SOHO 2022 Tenth Annual Meeting

H. Kantarjian

1.7K views
10:33

Next Questions: ALL

Lori Muffly

142 views
11:20

SOHO 2022: Orca-T Results in High GVHD-Free and Relapse-Free Surviva…

SOHO 2022 Tenth Annual Meeting

S. Srour

13 views
15:25

Supportive Therapy in CLL

SOHO 2022 Tenth Annual Meeting

C. Sun

60 views
14:10

CLL - Real World Data With Small Molecules

SOHO 2022 Tenth Annual Meeting

F. Cymbalista

68 views
14:13

CLL DEBATE: How Many Drugs Are Needed in 1L CLL?

SOHO 2022 Tenth Annual Meeting

A. Mato

96 views
15:03

CLL DEBATE: Combination Small Molecules vs. Sequencing in CLL - Pro …

SOHO 2022 Tenth Annual Meeting

J. Brown

94 views
13:53

SOHO 2022: Covalent BTK Inhibitors - How Do They Compare in CLL?

SOHO 2022 Tenth Annual Meeting

J. Byrd

43 views
15:10

Clinical Significance of B-Cell Receptor Stereotypy in CLL

SOHO 2022 Tenth Annual Meeting

K. Stamatopoulos

59 views
10:34

SOHO 2022: PACE and OPTIC Trials - Dose Modification Dynamics of Pon…

SOHO 2022 Tenth Annual Meeting

H. Kantarjian

73 views
16:33

SOHO 2022: Asciminib or Ponatinib for Multiresistant CML Patients?

SOHO 2022 Tenth Annual Meeting

J. Cortés

34 views
14:57

SOHO 2022: Immunotherapy - The Way Forward to Maximize TFR in CML?

SOHO 2022 Tenth Annual Meeting

D. Rea

9 views
13:34

SOHO 2022: Beyond TKI Therapy in CML

SOHO 2022 Tenth Annual Meeting

M. Copland

14 views
09:52

SOHO 2022: AGILE - A Phase 3, Global, Randomized, Double-Blind Study…

SOHO 2022 Tenth Annual Meeting

A. de la Fuente, C. DiNardo

19 views
16:04

SOHO 2022: Emerging CAR T-Cell Therapy Approaches in AML

SOHO 2022 Tenth Annual Meeting

S. Kenderian

31 views
15:39

SOHO 2022 AML DEBATE: Is MRD More Prognostic Than Initial Presentati…

SOHO 2022 Tenth Annual Meeting

C. Lindsley

17 views
16:37

SOHO 2022 AML DEBATE: Is MRD More Prognostic Than Initial Presentati…

SOHO 2022 Tenth Annual Meeting

M. Heuser

14 views
14:41

Is the Future of AML Therapy All Oral?

Farhad Ravandi

160 views
14:50

SOHO 2022: Non-Intensive Treatment of Elderly/Unfit Patients With AML

SOHO 2022 Tenth Annual Meeting

T. Kadia

28 views
15:45

SOHO 2022: How Do We Overcome Resistance to Venetoclax in AML

SOHO 2022 Tenth Annual Meeting

M. Konopleva

884 views
15:21

SOHO 2022: FLT3-Mutated AML - Triplet vs. Doublet Therapy

SOHO 2022 Tenth Annual Meeting

E. Wang

26 views
15:13

SOHO 2022: Menin Inhibitors in AML

SOHO 2022 Tenth Annual Meeting

E. Stein

213 views
17:07

SOHO 2022: Novel Chemotherapy Can Eliminate the Need for Transplant …

SOHO 2022 Tenth Annual Meeting

N. Short

64 views
11:49

SOHO 2022: Certain Patients With ALL Still Need a Transplant

SOHO 2022 Tenth Annual Meeting

J. Ribera, P. Scheinberg

14 views
15:52

SOHO 2022: Approach to ALL in the Elderly

SOHO 2022 Tenth Annual Meeting

M. Luskin

26 views
13:46

SOHO 2022: Management of Ph+ ALL in 2022

SOHO 2022 Tenth Annual Meeting

E. Jabbour

127 views
06:35

SOHO 2022: Phase II Study of Blinatumomab in Combination With Ponati…

SOHO 2022 Tenth Annual Meeting

F. Haddad

79 views

SOHO 2022: Dual Targeted CAR T-Cells for ALL

SOHO 2022 Tenth Annual Meeting

N. Frey

10 views
12:49

SOHO 2022: Approach to Ph-Like ALL

SOHO 2022 Tenth Annual Meeting

E. Curran

34 views
16:13

SOHO 2022: Blinatumomab in Pediatric ALL

SOHO 2022 Tenth Annual Meeting

S. Cooper

42 views
12:06

New BTKi in CLL

Catherine Coombs

248 views
09:23

Novel Agents in CLL

SOHO 2022 Tenth Annual Meeting

A. Danilov

66 views
11:07

SOHO 2022: BCL2i in CLL

SOHO 2022 Tenth Annual Meeting

A. Chanan-Khan

83 views
08:48

SOHO 2022: Childhood CML

SOHO 2022 Tenth Annual Meeting

F. Millot

11 views
20:12

SOHO 2022: Assessment and Management of TKI-Related AOEs in CML

SOHO 2022 Tenth Annual Meeting

G. Saglio

26 views
13:09

SOHO 2022: Non BCR-ABL Mutations in CML - Do They Matter?

SOHO 2022 Tenth Annual Meeting

S. Soverini

21 views
15:43

SOHO 2022: Advances in ALL Diagnosis and Treatment - The NOPHO Exper…

SOHO 2022 Tenth Annual Meeting

K. Schmiegelow

15 views
09:08

Approaches to and Use of MRD in ALL

Selina Luger

75 views
11:13

SOHO 2022: Allogeneic CAR T-Cells in ALL

SOHO 2022 Tenth Annual Meeting

N. Jain

26 views
12:26

SOHO 2022: Is TP53-Mutated AML the Same Disease as TP53-Mutated MDS?

SOHO 2022 Tenth Annual Meeting

P. Valk

37 views
19:33

SOHO 2022 Update on CD47 Targeting Antibodies

SOHO 2022 Tenth Annual Meeting

N. Daver

33 views
20:35

SOHO 2022: What Is the Best Strategy for Therapy-Related AML?

SOHO 2022 Tenth Annual Meeting

P. Desai

47 views